We conduct the present study in order to evaluate the association between clinical presentations, brain images, tumor cell counting of CSF, and EGFR mutation detection rates among EGFR-mutant lung adenocarcinoma patients with LM. The gene discussed is EGFR; the disease is neoplasm.